183 related articles for article (PubMed ID: 38473753)
21. The role of vitamin D in breast cancer risk and progression.
Vanhevel J; Verlinden L; Doms S; Wildiers H; Verstuyf A
Endocr Relat Cancer; 2022 Jan; 29(2):R33-R55. PubMed ID: 34935629
[TBL] [Abstract][Full Text] [Related]
22. Cross-talk of Aryl Hydrocarbon Receptor (AHR)- and Vitamin D Receptor (VDR)-signaling in Human Keratinocytes.
Christofi C; Lamnis L; Stark A; Palm H; Römer K; Vogt T; Reichrath J
Anticancer Res; 2022 Oct; 42(10):5049-5067. PubMed ID: 36191995
[TBL] [Abstract][Full Text] [Related]
23. 1,25-Dihydroxyvitamin D
Li M; Li L; Zhang L; Hu W; Shen J; Xiao Z; Wu X; Chan FL; Cho CH
Life Sci; 2017 Jun; 179():88-97. PubMed ID: 28465245
[TBL] [Abstract][Full Text] [Related]
24. A new series of vitamin D analogs is highly active for clonal inhibition, differentiation, and induction of WAF1 in myeloid leukemia.
Munker R; Kobayashi T; Elstner E; Norman AW; Uskokovic M; Zhang W; Andreeff M; Koeffler HP
Blood; 1996 Sep; 88(6):2201-9. PubMed ID: 8822940
[TBL] [Abstract][Full Text] [Related]
25. Role of 1α,25-Dihydroxyvitamin D3 in Adipogenesis of SGBS Cells: New Insights into Human Preadipocyte Proliferation.
Felicidade I; Sartori D; Coort SLM; Semprebon SC; Niwa AM; D'Epiro GFR; Biazi BI; Marques LA; Evelo CT; Mantovani MS; Ribeiro LR
Cell Physiol Biochem; 2018; 48(1):397-408. PubMed ID: 30016791
[TBL] [Abstract][Full Text] [Related]
26. 24-Hydroxylase in cancer: impact on vitamin D-based anticancer therapeutics.
Luo W; Hershberger PA; Trump DL; Johnson CS
J Steroid Biochem Mol Biol; 2013 Jul; 136():252-7. PubMed ID: 23059474
[TBL] [Abstract][Full Text] [Related]
27. Resistance of HBL100 human breast epithelial cells to vitamin D action.
Agadir A; Lazzaro G; Zheng Y; Zhang XK; Mehta R
Carcinogenesis; 1999 Apr; 20(4):577-82. PubMed ID: 10223184
[TBL] [Abstract][Full Text] [Related]
28. Vitamin D regulates tyrosine hydroxylase expression: N-cadherin a possible mediator.
Cui X; Pertile R; Liu P; Eyles DW
Neuroscience; 2015 Sep; 304():90-100. PubMed ID: 26210580
[TBL] [Abstract][Full Text] [Related]
29. Vitamin D receptor expression and associated gene signature in tumour stromal fibroblasts predict clinical outcome in colorectal cancer.
Ferrer-Mayorga G; Gómez-López G; Barbáchano A; Fernández-Barral A; Peña C; Pisano DG; Cantero R; Rojo F; Muñoz A; Larriba MJ
Gut; 2017 Aug; 66(8):1449-1462. PubMed ID: 27053631
[TBL] [Abstract][Full Text] [Related]
30. Fibroblast Growth Factor Receptor Signaling in Skin Cancers.
Czyz M
Cells; 2019 Jun; 8(6):. PubMed ID: 31167513
[TBL] [Abstract][Full Text] [Related]
31. Eldecalcitol (ED-71), an analog of 1α,25(OH)
Shintani T; Takatsu F; Rosli SNZ; Usui E; Hamada A; Sumi K; Hayashido Y; Toratani S; Okamoto T
In Vitro Cell Dev Biol Anim; 2017 Oct; 53(9):810-817. PubMed ID: 28710602
[TBL] [Abstract][Full Text] [Related]
32. Endocrine actions of vitamin D in skin: Relevance for photocarcinogenesis of non-melanoma skin cancer, and beyond.
Reichrath J; Saternus R; Vogt T
Mol Cell Endocrinol; 2017 Sep; 453():96-102. PubMed ID: 28526240
[TBL] [Abstract][Full Text] [Related]
33. Notch- and vitamin D signaling in 1,25(OH)2D3-resistant glioblastoma multiforme (GBM) cell lines.
Reichrath S; Müller CS; Gleissner B; Pfreundschuh M; Vogt T; Reichrath J
J Steroid Biochem Mol Biol; 2010 Jul; 121(1-2):420-4. PubMed ID: 20206691
[TBL] [Abstract][Full Text] [Related]
34. Effects of FGFR inhibitors TKI258, BGJ398 and AZD4547 on breast cancer cells in 2D, 3D and tissue explant cultures.
Kähkönen TE; Toriseva M; Petruk N; Virta AR; Maher A; Eigéliené N; Kaivola J; Boström P; Koskivuo I; Nees M; Tuomela JM; Ivaska KK; Härkönen PL
Cell Oncol (Dordr); 2021 Feb; 44(1):205-218. PubMed ID: 33119860
[TBL] [Abstract][Full Text] [Related]
35. Expression of fibroblast growth factor receptors in naevus-cell naevus and malignant melanoma.
Ahmed NU; Ueda M; Ito A; Ohashi A; Funasaka Y; Ichihashi M
Melanoma Res; 1997 Aug; 7(4):299-305. PubMed ID: 9293479
[TBL] [Abstract][Full Text] [Related]
36. Targeting the vitamin D endocrine system (VDES) for the management of inflammatory and malignant skin diseases: An historical view and outlook.
Reichrath J; Zouboulis CC; Vogt T; Holick MF
Rev Endocr Metab Disord; 2016 Sep; 17(3):405-417. PubMed ID: 27447175
[TBL] [Abstract][Full Text] [Related]
37. AZD4547 and calcitriol synergistically inhibited BT-474 cell proliferation while modified stemness and tumorsphere formation.
Morales-Guadarrama G; Méndez-Pérez EA; García-Quiroz J; Avila E; Larrea F; Díaz L
J Steroid Biochem Mol Biol; 2022 Oct; 223():106132. PubMed ID: 35659529
[TBL] [Abstract][Full Text] [Related]
38. On the role of classical and novel forms of vitamin D in melanoma progression and management.
Slominski AT; Brożyna AA; Skobowiat C; Zmijewski MA; Kim TK; Janjetovic Z; Oak AS; Jozwicki W; Jetten AM; Mason RS; Elmets C; Li W; Hoffman RM; Tuckey RC
J Steroid Biochem Mol Biol; 2018 Mar; 177():159-170. PubMed ID: 28676457
[TBL] [Abstract][Full Text] [Related]
39. Differential antitumor effects of vitamin D analogues on colorectal carcinoma in culture.
Wierzbicka JM; Binek A; Ahrends T; Nowacka JD; Szydłowska A; Turczyk Ł; Wąsiewicz T; Wierzbicki PM; Sądej R; Tuckey RC; Slominski AT; Chybicki J; Adrych K; Kmieć Z; Żmijewski MA
Int J Oncol; 2015 Sep; 47(3):1084-96. PubMed ID: 26260259
[TBL] [Abstract][Full Text] [Related]
40. 1α,25-Dihydroxyvitamin D
Ishizawa M; Akagi D; Yamamoto J; Makishima M
J Steroid Biochem Mol Biol; 2017 Sep; 172():55-61. PubMed ID: 28578001
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
